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Different Biology and Pathology of Minor Alloantigen-Specific
Cytotoxic and Proliferative Τ Cells
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r
 | ""HE role of individual T-cell subsets in the pathogene-
X sis of graft-versus-host disease (GvHD) in response
to minor histocompatibility (mH) antigen differences re-
mains poorly understood. In this study, cytotoxic Τ lym-
phocytes (CTL) specific for host mH antigens were fre-
quently detected in patients with and without GvHD,
indicating a discordance between this in vitro effector cell
population and the in vivo antihost response. In contrast,
a correlation was found between the activity of proliferat-
ing Τ lymphocytes (Th cells) against host mH antigens and
the development of acute GvHD. Based on these results a
different immunopathologic role for the antihost CTL and
Th-cell populations, also varying for several biological
properties, can be envisaged.
MATERIALS AND METHODS
Sixteen patients received non-T-cell-depleted bone marrow from
their HLA-A, B, Cw, DR-identical MLC nonreactive sibling
donors after conditioning with cyclophosphamide and total body
irradiation. Six patients had no GvHD (group A), five patients
developed acute GvHD (group B), and five patients developed
acute GvHD followed by chronic GvHD (group C). Peripheral
blood leukocytes (PBL) were obtained of heparinized blood
samples from patients before and at different times after bone
marrow transplantation (BMT), as well as from bone marrow
donors and healthy controls. T-cell lines were generated from
patients post-BMT PBL by restimulation in a host-specific man-
ner, and were functionally analyzed in chromium-release assays
and in proliferation tests for host mH antigen-specific T-cell
reactivities as described elsewhere.1 Α multivariate analysis of the
variance (MANOVA) was applied to determine the statistical
significance of differences in post-BMT CTL or Th-cell activities
found between different groups of patients.
RESULTS
Immunopathology
In total, 60 post-BMT T-cell lines were initiated and tested
for antihost CTL activity (n = 60) and Th-cell activity (n =
57). AU patients except two had antihost CTL activity in at
least one blood sample after BMT, irrespective of the
development of GvHD. In patients with chronic GvHD,
the mean antihost CTL activities were higher than in
patients with no or with acute GvHD, yet these diiferences
were not statistically significant (Fig. 1, upper panel).
Antibost Th-cell activity in one or more blood samples
post-BMT was detected in 10 of 16 patients, including all
five patients having acute GvHD. As is shown in the lower
panel of Fig 1, the latter patients had higher averaged
proliferation levels against the host than patients who had
no GvHD (P = .038) or patients having chronic GvHD
(P = .09).
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Fig 1. Antihost cytotoxic (upper panel, 9) and proliferative (lower
panel, •) T-cell activity measured in T-cell lines derived from
patients with (A) no GvHD, with (B) acute GvHD, or (C) with
chronic GvHD at different time intervals (I = 0-1W, II = 1 νέ-3; III =
3-6; IV = 6-9; V = 9-12; VI = 12-25 months after BMT).
Immunobiology
The phenotype and major histocompatibility complex
(MHC) restriction of the mH antigen CTL and Th cells
were defined through T-cell subset Isolation using anti-
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body-coated magnetic beads, specificity analyses using
large panels of HLA-typed target and stimulator cells, and
Inhibition studies with monoclonal antibodies (MAbs). The
CTL response was mediated by MHC class I-restricted
CD8+ Τ cells, whereas the Th-cell response was mediated
mainly by MHC class II-restricted CD4+ Τ cells (data
shown elsewhere2·3). Blocking of the latter cells using
class II locus-specific MAbs revealed a role for HLA-DR
as well as HLA-DP in mH antigen presentation. When
different types of mH antigens presenting cells (APC), host
pre-BMT PBL, and Epstein Barr virus-transformed B-cell
lines (EBV-BCL) were compared, the two mH antigen-
specific T-cell subsets showed different in vitro accessory
cell requirements (data shown elsewhere4). While EBV-
BCL were efficient APC for the induction of mH antigen-
specific CTL, they failed to induce the Th-cell counterpart
of the response, despite their normal stimulatory capacity
as secondary stimulator cells. It was suggested that EBV-
BCL failed to provide cosignal(s) selectively needed for
the Th-cell activation.
DISCUSSION
The activation of donor-derived Τ cells by host mH
antigens was frequently observed after HLA-identical
BMT. The cellular response included a cytotoxic part,
mediated by class I-restricted CD8+ Τ cells, and a prolif-
erative part, mediated by class II-restricted CD4+ Τ cells.
Possibly these subsets also differ in their requirement of
cosignals for activation. The assumption that these cell
subsets may be in vitro correlates for GvHD would imply
that potentially harmful effector cells are present in the
majority of patients. Clearly, the dissociation of the pres-
ence of antihost CTLs and the development of GvHD
questions the role of classical CTL as exclusive effector
cells in this disease. Mechanisms including host-specific
suppression5 or differential tissue distribution for mH
antigens6 could play a role in the acquirement of tolerance
in patients without clinical signs of GvHD. Alternatively,
our finding that high levels of antihost Th-cell activity was
associated with acute GvHD opens up another possible
explanation. Either antihost Th cells could directly cause
härm by the release of cytokines or the triggering of a
DTH-like reaction, or they could provide in vivo 'help' for
their cytotoxic counterparts. Analysis of the lymphokine
production patterns by these cell types should help to
elucidate this issue.
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